Extendicare Inc. Logo

Extendicare Inc.

0S9E.L

(0.0)
Stock Price

9,09 CAD

10.2% ROA

62.48% ROE

13.23x PER

Market Cap.

778.747.110,00 CAD

268.86% DER

5.14% Yield

4.28% NPM

Extendicare Inc. Stock Analysis

Extendicare Inc. Fundamental Analysis

Fundamental analysis in stock investing is like studying the foundation of a house before buying it. It involves looking at a company's financial health, like its earnings, assets, and debts, to determine if it's a good investment based on its fundamental strength and potential for growth.

Extendicare Inc. Fundamental Stock Analysis
# Analysis Rating
1 ROE

Unidentified ROE

2 ROA

Unidentified ROA

3 PBV

Unidentified ROA

4 DER

Unidentified DER

5 Revenue Growth

Regrettably, this company's revenue has shown no signs of growth over the past three years, suggesting limited potential for returns and making it a less appealing choice.

6 Net Profit Growth

Over the past five years, this company's net profit has failed to exhibit any growth, indicating a stagnant financial performance and making it a less favorable choice for potential investors.

7 Assets Growth

Company has experienced no growth in revenue over the past three years, suggesting limited profitability and making it a less desirable investment opportunity.

8 Graham Number

Unidentified Graham Number

9 Dividend Growth

Potential investors should be aware that the company's dividend growth has shown no upward trend in the past three years, indicating limited potential for increased returns.

10 Dividend

No dividends from the company in the past three years raises doubts about its profitability for shareholders.

11 Buffet Intrinsic Value

Warren Buffett's formula suggests that the company's stock is overpriced (0), presenting a possible disadvantage for investors as its market price surpasses its estimated intrinsic value.

Extendicare Inc. Technical Analysis

Technical analysis in stock investing is like reading the patterns on a weather map to predict future weather conditions. It involves studying past stock price movements and trading volumes to make predictions about where a stock's price might go next, without necessarily looking at the company's financial health.

Extendicare Inc. Technical Stock Analysis
# Analysis Recommendation
1 Awesome Oscillator Unknown
2 MACD Unknown
3 RSI Unknown
4 Stoch RSI Unknown

Extendicare Inc. Price Chart

Financial Statements

Financial statements are like report cards for companies. They show how much money a company makes (income statement), what it owns and owes (balance sheet), and where it spends its money (cash flow statement), helping stock investors understand if a company is healthy and worth investing in.

Income Statements

An income statement for a company is like a scoreboard for its profits and losses. It shows how much money the company made (revenue) and how much it spent to make that money (expenses), helping stock investors see if a company is making a profit or not.

Revenue in stock investing is the total amount of money a company earns from its sales, and it's a key factor that investors consider to assess a company's financial performance and growth potential.

Extendicare Inc. Revenue
Year Revenue Growth
1998 2.112.868.000
1999 1.892.687.000 -11.63%
2000 1.807.406.000 -4.72%
2001 1.704.511.000 -6.04%
2002 1.755.674.000 2.91%
2003 1.724.614.000 -1.8%
2004 1.746.800.000 1.27%
2005 1.971.768.000 11.41%
2006 1.745.472.000 -12.96%
2007 1.804.449.000 3.27%
2008 2.064.388.000 12.59%
2009 2.167.196.000 4.74%
2010 2.069.103.000 -4.74%
2011 2.094.082.000 1.19%
2012 2.037.413.000 -2.78%
2013 2.024.465.000 -0.64%
2014 816.119.000 -148.06%
2015 979.609.000 16.69%
2016 1.060.758.000 7.65%
2017 1.097.331.000 3.33%
2018 1.120.007.000 2.02%
2019 1.131.950.000 1.06%
2020 1.158.293.000 2.27%
2021 1.216.758.000 4.8%
2022 1.221.577.000 0.39%
2023 1.290.116.000 5.31%
2023 1.304.957.000 1.14%
2024 1.393.928.000 6.38%

Research and Development Expenses are the costs a company incurs to create and improve its products or services, which can be important for investors to evaluate a company's innovation and potential for future growth.

Extendicare Inc. Research and Development Expenses
Year Research and Development Expenses Growth
1998 0
1999 0 0%
2000 0 0%
2001 0 0%
2002 0 0%
2003 0 0%
2004 0 0%
2005 0 0%
2006 0 0%
2007 0 0%
2008 0 0%
2009 0 0%
2010 0 0%
2011 0 0%
2012 0 0%
2013 0 0%
2014 0 0%
2015 0 0%
2016 0 0%
2017 0 0%
2018 0 0%
2019 0 0%
2020 0 0%
2021 0 0%
2022 0 0%
2023 0 0%
2023 0 0%
2024 0 0%

General and Administrative Expenses are the costs a company incurs to run its day-to-day operations, such as office rent, salaries, and utilities, which investors consider to understand a company's overall efficiency and management effectiveness.

Extendicare Inc. General and Administrative Expenses
Year General and Administrative Expenses Growth
1998 0
1999 0 0%
2000 0 0%
2001 0 0%
2002 0 0%
2003 0 0%
2004 0 0%
2005 0 0%
2006 0 0%
2007 0 0%
2008 0 0%
2009 72.818.000 100%
2010 72.624.000 -0.27%
2011 0 0%
2012 74.141.000 100%
2013 75.354.000 1.61%
2014 33.357.000 -125.9%
2015 43.161.000 22.71%
2016 39.063.000 -10.49%
2017 38.225.000 -2.19%
2018 39.746.000 3.83%
2019 42.339.000 6.12%
2020 48.959.000 13.52%
2021 1.140.205.000 95.71%
2022 1.164.123.000 2.05%
2023 57.760.000 -1915.45%
2023 1.088.611.000 94.69%
2024 1.137.048.000 4.26%

EBITDA stands for Earnings Before Interest, Taxes, Depreciation, and Amortization. It is a measure that helps stock investors analyze a company's profitability by looking at its earnings without considering certain expenses. This helps to get a clearer picture of the company's financial performance and its ability to generate cash flow.

Extendicare Inc. EBITDA
Year EBITDA Growth
1998 335.773.000
1999 229.954.000 -46.02%
2000 198.418.000 -15.89%
2001 226.906.000 12.55%
2002 253.449.000 10.47%
2003 186.830.000 -35.66%
2004 224.592.000 16.81%
2005 268.611.000 16.39%
2006 276.148.000 2.73%
2007 208.421.000 -32.5%
2008 207.120.000 -0.63%
2009 290.449.000 28.69%
2010 254.526.000 -14.11%
2011 206.907.000 -23.01%
2012 179.937.000 -14.99%
2013 157.001.000 -14.61%
2014 120.623.000 -30.16%
2015 90.676.000 -33.03%
2016 100.595.000 9.86%
2017 98.687.000 -1.93%
2018 94.637.000 -4.28%
2019 91.981.000 -2.89%
2020 132.096.000 30.37%
2021 95.185.000 -38.78%
2022 53.111.000 -79.22%
2023 83.080.000 36.07%
2023 95.187.000 12.72%
2024 154.444.000 38.37%

Gross profit is the money a company makes from selling its products or services after subtracting the cost of producing or providing them, and it is an important measure for investors to understand a company's profitability.

Extendicare Inc. Gross Profit
Year Gross Profit Growth
1998 2.112.868.000
1999 1.892.687.000 -11.63%
2000 1.807.406.000 -4.72%
2001 1.704.511.000 -6.04%
2002 1.755.674.000 2.91%
2003 205.047.000 -756.23%
2004 240.822.000 14.86%
2005 297.993.000 19.19%
2006 204.327.000 -45.84%
2007 285.122.000 28.34%
2008 293.490.000 2.85%
2009 338.488.000 13.29%
2010 321.207.000 -5.38%
2011 269.291.000 -19.28%
2012 257.394.000 -4.62%
2013 231.097.000 -11.38%
2014 108.023.000 -113.93%
2015 128.258.000 15.78%
2016 130.136.000 1.44%
2017 104.094.000 -25.02%
2018 98.519.000 -5.66%
2019 93.665.000 -5.18%
2020 197.695.000 52.62%
2021 151.715.001 -30.31%
2022 76.829.000 -97.47%
2023 140.840.000 45.45%
2023 118.427.000 -18.93%
2024 178.212.000 33.55%

Net income in stock investing is like the money a company actually gets to keep as profit after paying all its bills, and it's an important measure to understand how well a company is doing financially.

Extendicare Inc. Net Profit
Year Net Profit Growth
1998 65.332.000
1999 -159.702.000 140.91%
2000 -59.278.000 -169.41%
2001 -36.406.000 -62.82%
2002 18.934.000 292.28%
2003 60.674.000 68.79%
2004 125.201.000 51.54%
2005 95.105.000 -31.65%
2006 -35.728.000 366.19%
2007 70.381.000 150.76%
2008 13.388.000 -425.7%
2009 77.708.000 82.77%
2010 51.687.000 -50.34%
2011 -30.396.000 270.05%
2012 62.656.000 148.51%
2013 5.252.000 -1092.99%
2014 -18.753.000 128.01%
2015 232.078.000 108.08%
2016 35.452.000 -554.63%
2017 2.132.000 -1562.85%
2018 31.738.000 93.28%
2019 17.051.000 -86.14%
2020 42.586.000 59.96%
2021 9.012.000 -372.55%
2022 -4.511.000 299.78%
2023 47.324.000 109.53%
2023 33.982.000 -39.26%
2024 103.560.000 67.19%

EPS, or earnings per share, is a measure that shows how much profit a company has earned for each outstanding share of its stock, and it is important for stock investors as it helps understand the profitability of a company and compare it with other companies in the market.

Extendicare Inc. Earning per Share (EPS)
Year Earning per Share (EPS) Growth
1998 1
1999 -2 100%
2000 -1 0%
2001 -1 0%
2002 0 0%
2003 1 0%
2004 2 100%
2005 1 0%
2006 -1 0%
2007 1 100%
2008 0 0%
2009 1 100%
2010 1 0%
2011 0 0%
2012 1 0%
2013 0 0%
2014 0 0%
2015 3 100%
2016 0 0%
2017 0 0%
2018 0 0%
2019 0 0%
2020 0 0%
2021 0 0%
2022 0 0%
2023 1 0%
2023 0 0%
2024 1 100%

Cashflow Statements

Cashflow statements show the movement of money in and out of a company, helping stock investors understand how much money a company makes and spends. By examining cashflow statements, investors can assess if a company is generating enough cash to pay its bills, invest in growth, and provide returns to stockholders.

Free cash flow is the leftover cash that a company generates after covering its operating expenses and capital expenditures, which is important for stock investors as it shows how much money a company has available to invest in growth, pay dividends, or reduce debt.

Extendicare Inc. Free Cashflow
Year Free Cashflow Growth
1998 -42.063.000
1999 -10.983.000 -282.98%
2000 1.357.000 909.36%
2001 91.029.000 98.51%
2002 45.131.000 -101.7%
2003 38.083.000 -18.51%
2004 154.840.000 75.4%
2005 54.965.000 -181.71%
2006 52.183.000 -5.33%
2007 40.625.000 -28.45%
2008 37.608.000 -8.02%
2009 93.531.000 59.79%
2010 79.404.000 -17.79%
2011 42.471.000 -86.96%
2012 24.684.000 -72.06%
2013 42.163.000 41.46%
2014 48.438.000 12.95%
2015 17.320.000 -179.67%
2016 -39.118.000 144.28%
2017 6.023.000 749.48%
2018 -11.175.000 153.9%
2019 12.008.000 193.06%
2020 88.165.000 86.38%
2021 -6.099.000 1545.56%
2022 -2.915.000 -109.23%
2023 -36.703.000 92.06%
2023 -105.348.000 65.16%
2024 34.619.000 404.31%

Operating cash flow represents the cash generated or consumed by a company's day-to-day operations, excluding external investing or financing activities, and is crucial for stock investors as it shows how much cash a company is generating from its core business operations.

Extendicare Inc. Operating Cashflow
Year Operating Cashflow Growth
1998 71.279.000
1999 39.285.000 -81.44%
2000 47.649.000 17.55%
2001 136.406.000 65.07%
2002 98.276.000 -38.8%
2003 102.430.000 4.06%
2004 223.962.000 54.26%
2005 136.177.000 -64.46%
2006 128.784.000 -5.74%
2007 115.587.000 -11.42%
2008 105.142.000 -9.93%
2009 185.125.000 43.2%
2010 149.357.000 -23.95%
2011 106.779.000 -39.87%
2012 108.787.000 1.85%
2013 97.916.000 -11.1%
2014 85.607.000 -14.38%
2015 52.798.000 -62.14%
2016 -281.000 18889.32%
2017 47.160.000 100.6%
2018 39.473.000 -19.47%
2019 45.190.000 12.65%
2020 121.265.000 62.73%
2021 63.424.000 -91.2%
2022 98.714.000 35.75%
2023 7.223.000 -1266.66%
2023 24.065.000 69.99%
2024 44.051.000 45.37%

Capex, short for capital expenditures, refers to the money a company spends on acquiring or upgrading tangible assets like buildings, equipment, or technology, which is important for stock investors as it indicates how much a company is investing in its infrastructure to support future growth and profitability.

Extendicare Inc. Capital Expenditure
Year Capital Expenditure Growth
1998 113.342.000
1999 50.268.000 -125.48%
2000 46.292.000 -8.59%
2001 45.377.000 -2.02%
2002 53.145.000 14.62%
2003 64.347.000 17.41%
2004 69.122.000 6.91%
2005 81.212.000 14.89%
2006 76.601.000 -6.02%
2007 74.962.000 -2.19%
2008 67.534.000 -11%
2009 91.594.000 26.27%
2010 69.953.000 -30.94%
2011 64.308.000 -8.78%
2012 84.103.000 23.54%
2013 55.753.000 -50.85%
2014 37.169.000 -50%
2015 35.478.000 -4.77%
2016 38.837.000 8.65%
2017 41.137.000 5.59%
2018 50.648.000 18.78%
2019 33.182.000 -52.64%
2020 33.100.000 -0.25%
2021 69.523.000 52.39%
2022 101.629.000 31.59%
2023 43.926.000 -131.36%
2023 129.413.000 66.06%
2024 9.432.000 -1272.06%

Balance Sheet

Balance sheets provide a snapshot of a company's financial health and its assets (such as cash, inventory, and property) and liabilities (like debts and obligations) at a specific point in time. For stock investors, balance sheets help assess the company's overall worth and evaluate its ability to meet financial obligations and support future growth.

Equity refers to the ownership interest or stake that shareholders have in a company, representing their claim on its assets and earnings after all debts and liabilities are paid.

Extendicare Inc. Equity
Year Equity Growth
1998 658.625.000
1999 437.380.000 -50.58%
2000 382.024.000 -14.49%
2001 350.696.000 -8.93%
2002 358.026.000 2.05%
2003 356.433.000 -0.45%
2004 456.987.000 22%
2005 497.306.000 8.11%
2006 -23.654.000 2202.42%
2007 -23.578.000 -0.32%
2008 -29.532.000 20.16%
2009 -40.903.000 27.8%
2010 18.687.000 318.88%
2011 48.319.000 61.33%
2012 54.660.000 11.6%
2013 37.866.000 -44.35%
2014 -2.504.000 1612.22%
2015 172.129.000 101.45%
2016 174.759.000 1.5%
2017 128.956.000 -35.52%
2018 125.991.000 -2.35%
2019 115.414.000 -9.16%
2020 128.188.000 9.97%
2021 101.923.000 -25.77%
2022 100.701.000 -1.21%
2023 95.629.000 -5.3%
2023 87.920.000 -8.77%
2024 106.695.000 17.6%

Assets represent the valuable resources that a company owns, such as cash, inventory, property, and equipment, and understanding a company's assets helps investors assess its value and potential for generating future profits.

Extendicare Inc. Assets
Year Assets Growth
1998 2.221.838.000
1999 1.834.123.000 -21.14%
2000 1.735.752.000 -5.67%
2001 1.740.246.000 0.26%
2002 1.809.836.000 3.85%
2003 1.593.417.000 -13.58%
2004 1.426.331.000 -11.71%
2005 1.698.094.000 16%
2006 1.315.182.000 -29.11%
2007 1.440.163.000 8.68%
2008 1.805.982.000 20.26%
2009 1.668.065.000 -8.27%
2010 1.698.010.000 1.76%
2011 1.830.704.000 7.25%
2012 1.807.916.000 -1.26%
2013 1.849.088.000 2.23%
2014 1.915.286.000 3.46%
2015 1.026.947.000 -86.5%
2016 988.617.000 -3.88%
2017 934.281.000 -5.82%
2018 896.324.000 -4.23%
2019 888.800.000 -0.85%
2020 963.127.000 7.72%
2021 900.323.000 -6.98%
2022 781.579.000 -15.19%
2023 687.994.000 -13.6%
2023 672.731.000 -2.27%
2024 706.336.000 4.76%

Liabilities refer to the financial obligations or debts that a company owes to creditors or external parties, and understanding a company's liabilities is important for investors as it helps assess the company's financial risk and ability to meet its obligations.

Extendicare Inc. Liabilities
Year Liabilities Growth
1998 1.563.213.000
1999 1.396.743.000 -11.92%
2000 1.353.728.000 -3.18%
2001 1.389.550.000 2.58%
2002 1.451.810.000 4.29%
2003 1.236.984.000 -17.37%
2004 969.344.000 -27.61%
2005 1.200.788.000 19.27%
2006 1.338.836.000 10.31%
2007 1.463.741.000 8.53%
2008 1.835.514.000 20.25%
2009 1.708.968.000 -7.4%
2010 1.679.323.000 -1.77%
2011 1.782.385.000 5.78%
2012 1.753.256.000 -1.66%
2013 1.811.222.000 3.2%
2014 1.917.790.000 5.56%
2015 854.818.000 -124.35%
2016 813.858.000 -5.03%
2017 805.325.000 -1.06%
2018 770.333.000 -4.54%
2019 773.386.000 0.39%
2020 834.939.000 7.37%
2021 798.400.000 -4.58%
2022 680.878.000 -17.26%
2023 592.365.000 -14.94%
2023 584.811.000 -1.29%
2024 599.641.000 2.47%

Extendicare Inc. Financial Ratio (TTM)

Valuation Metrics

Revenue per Share
16.47
Net Income per Share
0.71
Price to Earning Ratio
13.23x
Price To Sales Ratio
0.56x
POCF Ratio
7.13
PFCF Ratio
28.37
Price to Book Ratio
7.37
EV to Sales
0.7
EV Over EBITDA
7.46
EV to Operating CashFlow
8.77
EV to FreeCashFlow
35.25
Earnings Yield
0.08
FreeCashFlow Yield
0.04
Market Cap
0,78 Bil.
Enterprise Value
0,97 Bil.
Graham Number
4.48
Graham NetNet
-4.75

Income Statement Metrics

Net Income per Share
0.71
Income Quality
1.86
ROE
0.62
Return On Assets
0.08
Return On Capital Employed
0.27
Net Income per EBT
0.79
EBT Per Ebit
0.9
Ebit per Revenue
0.06
Effective Tax Rate
0.23

Margins

Sales, General, & Administrative to Revenue
0.98
Research & Developement to Revenue
0
Stock Based Compensation to Revenue
0
Gross Profit Margin
0.1
Operating Profit Margin
0.06
Pretax Profit Margin
0.05
Net Profit Margin
0.04

Dividends

Dividend Yield
0.05
Dividend Yield %
5.14
Payout Ratio
0.67
Dividend Per Share
0.48

Operating Metrics

Operating Cashflow per Share
1.31
Free CashFlow per Share
0.33
Capex to Operating CashFlow
0.75
Capex to Revenue
0.06
Capex to Depreciation
2.41
Return on Invested Capital
0.19
Return on Tangible Assets
0.1
Days Sales Outstanding
21.64
Days Payables Outstanding
65.61
Days of Inventory on Hand
0
Receivables Turnover
16.87
Payables Turnover
5.56
Inventory Turnover
0
Capex per Share
0.98

Balance Sheet

Cash per Share
1,63
Book Value per Share
1,27
Tangible Book Value per Share
-0.2
Shareholders Equity per Share
1.27
Interest Debt per Share
3.66
Debt to Equity
2.69
Debt to Assets
0.41
Net Debt to EBITDA
1.46
Current Ratio
0.6
Tangible Asset Value
-0,02 Bil.
Net Current Asset Value
-0,36 Bil.
Invested Capital
243613000
Working Capital
-0,16 Bil.
Intangibles to Total Assets
0.18
Average Receivables
0,09 Bil.
Average Payables
0,23 Bil.
Average Inventory
0.5
Debt to Market Cap
0.37

Dividends

Dividends in stock investing are like rewards that companies give to their shareholders. They are a portion of the company's profits distributed to investors, typically in the form of cash payments, as a way for them to share in the company's success.

Extendicare Inc. Dividends
Year Dividends Growth
2023 0
2024 0 0%

Extendicare Inc. Profile

About Extendicare Inc.

Extendicare Inc., through its subsidiaries, provides care and services for seniors in Canada. The company offers long term care (LTC) services; retirement living services; and home health care services, such as nursing care, occupational, physical and speech therapy, and assistance with daily activities, as well as contract and consulting services to third parties. It operates a network of 119 LTC homes and retirement communities, as well as home health care operations under the Extendicare, Esprit Lifestyle Communities, ParaMed, Extendicare Assist, and SGP Purchasing Partner Network brands. Extendicare Inc. was founded in 1968 and is based in Markham, Canada.

CEO
Dr. Michael R. Guerriere M.D.,
Employee
23.500
Address
3000 Steeles Avenue East
Markham, L3R 4T9

Extendicare Inc. Executives & BODs

Extendicare Inc. Executives & BODs
# Name Age
1 Ms. Danielle Labossiere Parr
Vice President of Public Affairs
70
2 Dr. Michael R. Guerriere M.D., MBA
Chief Executive Officer, President & Director
70
3 Dr. Matthew Morgan
Chief Medical Officer
70
4 Ms. Katie LeMoyne
Senior Vice President & Chief Human Resources Officer
70
5 Mr. John Toffoletto
Senior Vice President, Chief Legal Officer & Corporate Secretary
70
6 Joe Belinsky
Vice President of Information Technology & Chief Information Officer
70
7 Mr. Steve Paraskevopoulos
Senior Vice President of ParaMed & Chief Technology Officer
70
8 Ms. Kathryn Killoran Bradley
Vice President of Corporate Development
70
9 Mr. David E. Bacon
Senior Vice President & Chief Financial Officer
70
10 Ms. Jillian E. Fountain
Vice President of Investor Relations
70

Extendicare Inc. Competitors